Free press releases distribution network?

Agency / Source: FTPB (French Technology Press Bureau)

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



bioMérieux to Present Latest Research at International AIDS Conference - France based bioMérieux, a world leader in the field of in-vitro diagnostics, is organising an integrated symposium entitled Viral Diagnosis is key in the fight against AIDS at the XVII International AIDS Conference, which is being held in Mexico City
bioMérieux to Present Latest Research at International AIDS Conference

 

PRZOOM - /newswire/ - London, United Kingdom, 2008/08/07 - France based bioMérieux, a world leader in the field of in-vitro diagnostics, is organising an integrated symposium entitled Viral Diagnosis is key in the fight against AIDS at the XVII International AIDS Conference, which is being held in Mexico City.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The XVII International AIDS Conference, which is being held in Mexico City from 3 to 8 August 2008. bioMérieux offers innovative diagnostic solutions for HIV management.

During the XVII International AIDS Conference, keynote speakers from Europe, Latin America and Africa will address issues including the importance of early detection of HIV infection, the relevance of rapid testing for epidemiology studies, the use of Dried Blood Spots for routine viral-load testing in remote areas, and the experience of South Africa in routine high-volume viral-load testing.

bioMérieux, a world leader in the field of in-vitro diagnostics, offers innovative diagnostic solutions for HIV management. The company provides one of the widest product ranges available to laboratories (with the exception of the US market) for diagnosing and monitoring HIV infection. It is committed to making innovation in HIV testing accessible to all types of healthcare settings and systems.

Today, the company’s unique range of solutions covers third- and fourth-generation screening tests in a variety of formats (automated immunoanalyzers, microplates for high volumes, and rapid manual tests), as well as molecular tests for real-time viral-load monitoring. One of the latest advances in viral-load monitoring and the most recent development in the bioMérieux range is the Dry Blood Spot. Currently used for research purposes, bioMérieux plans to expand the availability of this simple test to bring viral load monitoring to patients in remote areas.

Diagnostic screening and viral-load monitoring tests play a critical role in the early detection and management of HIV infection. These tests make it possible to prevent further transmission and improve patient care through timely initiation of treatment and regular follow-up.

HIV/AIDS represents a major and global public-health burden. In 2007, a total of 33.2 million people were estimated to be living with HIV, and the number of deaths from AIDS was 2.1 million (2007 Report on the Global AIDS Epidemic, UNAIDS). In the face of this epidemic, prevention and early diagnosis of HIV infection using screening tests are essential to provide the best patient care, and prevent further HIV transmission to uninfected partners and relations. With regular viral-load monitoring, patients can benefit from enhanced quality of life through better adapted therapy and rapid detection of resistance to treatment. Diagnostic tests also contribute significantly to the prevention of mother-to-child transmission.

bioMérieux’s commitment to HIV testing started 25 years ago, at the very beginning of the epidemic. Following the discovery of the HIV virus in 1983, the company’s research teams developed one of the first screening tests available, in 1985. Since then, a constant stream of innovative tests and technologies has been developed to respond to new and changing needs in HIV testing.

In addition to its comprehensive product range, bioMérieux actively drives the fight against HIV by regularly initiating high-level scientific symposia to further the exchange of knowledge on this key public-health issue. The company also works in close partnership with an international network of research institutes, biotechnology companies and physicians to further advance progress in the field of HIV diagnostics.

About bioMérieux

bioMérieux (biomerieux.com) has been a world leader in the field of in-vitro diagnostics for 45 years, and is present in more than 150 countries through 38 subsidiaries and a large network of distributors. In 2007, its revenues reached €1,063 billion, with 84% of sales generated outside France.

bioMérieux provides diagnostic solutions (reagents, instruments and software), which determine the source of disease and contamination so as to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cardiovascular emergencies, as well as cancer screening and monitoring. These products are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the NYSE Euronext Paris market (Code: BIM – Code ISIN: FR0010096479).

bioMérieux is taking part in the XVII International AIDS Conference, which is being held in Mexico City (Mexico) from 3 to 8 August 2008.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: FTPB (French Technology Press Bureau)

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


bioMérieux to Present Latest Research at International AIDS Conference

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Kate Ambler - UBIFRANCE.fr 
+44(0)20 7235 5330 contact.ftpb[.]ubifrance.fr
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any FTPB (French Technology Press Bureau) securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From FTPB (French Technology Press Bureau) / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today